Loading...
Loading...
- Celgene Corporation CELG is 'Too cheap to ignore'.
- Upgraded from Neutral to Overweight with price target of $152.
- Fell after the open buy found support below Wednesday's close ($108.17) at $107.51.
- Now that it has cleared $109.51, in an area with little resistance until $115.68.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
